Amyloid-β immunotherapy for Alzheimer's disease: the end of the beginning (original) (raw)

• Senior, K. Dosing in phase II trial of Alzheimer's vaccine suspended. Lancet Neurol. 1, 3 (2002).
  Article Google Scholar
• Tanzi, R. E. et al. The gene defects responsible for familial Alzheimer's disease. Neurobiol. Dis. 3, 159–168 (1996).
  Article CAS Google Scholar
• Hardy, J. New insights into the genetics of Alzheimer's disease. Ann. Med. 28, 255–258 (1996).
  Article CAS Google Scholar
• Citron, M. et al. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature 360, 672–674 (1992).
  Article CAS Google Scholar
• Citron, M. et al. Mutant presenilins of Alzheimer's disease increase production of 42 residue amyloid β-protein in both transfected cells and transgenic mice. Nature Med. 3, 67–72 (1997).
  Article CAS Google Scholar
• Suzuki, N. et al. An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (β APP717) mutants. Science 264, 1336–1340 (1994).
  Article CAS Google Scholar
• Borchelt, D. R. et al. Familial Alzheimer's disease-linked presenilin I variants elevate Aβ1–42/1–40 ratio in vitro and in vivo. Neuron 17, 1005–1013 (1996).
  Article CAS Google Scholar
• Scheuner, D. et al. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2, 864–870 (1996).
  Article CAS Google Scholar
• Schenk D. et al. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400, 173–177 (1999).
  Article CAS Google Scholar
• Janus, C. et al. A β peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 408, 979–982 (2000).
  Article CAS Google Scholar
• Morgan, D. et al. A β peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 408, 982–985 (2000).
  Article CAS Google Scholar
• Sigurdsson, E. M., Scholtzova, H., Mehta, P. D., Frangione, B. & Wisniewski, T. Immunization with a non-toxic/nonfibrillar amyloid-β homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice. Am. J. Pathol. 159, 439–447 (2001).
  Article CAS Google Scholar
• Bard, F. et al. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer's disease. Nature Med. 6, 916–919 (2000).
  Article CAS Google Scholar
• DeMattos, R. B. et al. Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease. Proc. Natl Acad. Sci. USA 98, 8850–8855 (2001).
  Article CAS Google Scholar
• DeMattos, R. B., Bales, K. R., Cummins, D. J., Paul, S. M. & Holtzman, D. M. Brain to plasma amyloid-β efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease. Science 295, 2264–2267 (2002).
  Article CAS Google Scholar
• Dodart, J. C. et al. Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease model. Nature Neurosci. 5, 452–457 (2002).
  Article CAS Google Scholar
• Solomon, B., Koppel, R., Hanan, E. & Katzav, T. Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer β-amyloid peptide. Proc. Natl Acad. Sci. USA 93, 452–455 (1996).
  Article CAS Google Scholar
• Solomon, B., Koppel, R., Frenkel, D. & Hanan-Aharon, E. Disaggregation of Alzheimer β-amyloid by site-directed mAb. Proc. Natl Acad. Sci. USA 94, 4109–4112 (1997).
  Article CAS Google Scholar
• Bacskai, B. et al. Non-Fc mediated mechanisms are involved in clearance of amyloid-β in vivo by immunotherapy. J. Neurosci. 22, 7862–7872 (2002).
  Article Google Scholar
• Frenkel, D., Katz, O. & Solomon, B. Immunization against Alzheimer's β-amyloid plaques via EFRH phage administration. Proc. Natl Acad. Sci. USA 97, 11455–11459 (2000).
  Article CAS Google Scholar
• Lopez, J. C. The comeback of immunization. Nature Rev. Neurosci. 3, 330 (2002).
  Article CAS Google Scholar
• Hock, C. Vaccination therapy for Alzheimer's disease. Neurobiol. Aging 23, S143 (2002).
  Google Scholar
• Monsonego, A. et al. Immunogenic aspects of amyloid β-peptide: implications for pathogenesis and treatment of Alzheimer's disease Neurobiol. Aging 23, S112 (2002).
  Google Scholar